| Identification | Back Directory | [Name]
2,6-diaminopurine dioxolane | [CAS]
145514-04-1 | [Synonyms]
Dapd
AMDX
Aids005431
Aids-005431
2,6-diaminopurine dioxolane
(-)-.beta.-D-2,6-Diaminopurine dioxolane
[(2R,4R)-4-(2,6-diaminopurin-9-yl)-1,3-dioxolan-2-yl]methanol
(2R,4R)-4-(2,6-DIAMINO-9H-PURIN-9-YL)-1,3-DIOXOLAN-2-YLMETHANOL
(-)-(2R,4R)-2-Amino-[2-(hydroxymethyl)-1,3-dioxolan-4-yl]adenine
1,3-Dioxolane-2-methanol, 4-(2,6-diamino-9H-purin-9-yl)-, (2R,4R)- | [Molecular Formula]
C9H12N6O3 | [MDL Number]
MFCD00871418 | [MOL File]
145514-04-1.mol | [Molecular Weight]
252.23 |
| Chemical Properties | Back Directory | [Melting point ]
237-239 °C(Solv: ethanol (64-17-5)) | [Boiling point ]
676.8±65.0 °C(Predicted) | [density ]
2.08±0.1 g/cm3(Predicted) | [pka]
14.83±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
2,6-diaminopurine dioxolane can be used in the treatment of HIV-1 and hepatitis B infections (reverse transcriptase inhibitor). |
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Website: |
www.lgmpharma.com |
|